ALLR

Allarity Therapeutics (ALLR)

About Allarity Therapeutics (ALLR)

Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.

Details

Daily high

$1.11

Daily low

$1.06

Price at open

$1.07

52 Week High

$2.35

52 Week Low

$0.61

Market cap

16.8M

Dividend yield

0.00%

Volume

121,860

Avg. volume

178,614

P/E ratio

-.66

Allarity Therapeutics News